Mytrex Health Technologies, Inc. (TPEX:4431)
Taiwan · Delayed Price · Currency is TWD 17.70
-0.05 (-0.28%)
Apr 17, 2026, 1:31 PM CST
TPEX:4431 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -16.6 | -82.38 | -56.22 | -91.9 | -14.01 |
Depreciation & Amortization | 73.73 | 89.71 | 91.29 | 102.48 | 50.6 |
Other Amortization | - | 5.76 | 5.7 | 4.03 | - |
Loss (Gain) From Sale of Assets | 2.77 | -17.51 | 4.1 | -8.68 | 0.16 |
Asset Writedown & Restructuring Costs | 1.26 | 41.65 | -0.92 | 51.47 | 25.65 |
Loss (Gain) From Sale of Investments | - | - | - | - | -33.34 |
Loss (Gain) on Equity Investments | -1.08 | 0.26 | -0.94 | -1.66 | 0.86 |
Stock-Based Compensation | - | - | - | - | -2.9 |
Provision & Write-off of Bad Debts | 0.14 | 0.68 | 1.27 | -0.12 | -0.02 |
Other Operating Activities | -12.93 | -6.29 | -8.19 | 17.99 | -74.51 |
Change in Accounts Receivable | 13.79 | 23.52 | -55.78 | 18.52 | 45.13 |
Change in Inventory | -9.89 | 2.26 | -18.64 | 3.47 | 41.96 |
Change in Accounts Payable | 132.21 | 53.61 | 71 | -8.42 | -3.4 |
Change in Unearned Revenue | 0.49 | -1.33 | 1.05 | -1.27 | -2.43 |
Change in Other Net Operating Assets | 16.63 | -78.31 | -37.97 | -13.43 | -20.47 |
Operating Cash Flow | 200.5 | 31.63 | -4.26 | 72.48 | 13.29 |
Operating Cash Flow Growth | 533.90% | - | - | 445.52% | -96.99% |
Capital Expenditures | -4.33 | -8.88 | -21.77 | -35.5 | -29.75 |
Sale of Property, Plant & Equipment | 0.31 | 49.9 | 2.38 | 9.59 | 2.4 |
Cash Acquisitions | - | - | -230 | - | - |
Sale (Purchase) of Intangibles | -1.49 | -6.16 | -3.24 | -7.81 | -0.59 |
Investment in Securities | -120.5 | - | - | -52.24 | 12.81 |
Other Investing Activities | 11.33 | 28.51 | -15.66 | -1.95 | -15.95 |
Investing Cash Flow | -114.68 | 63.36 | -268.29 | -87.91 | -31.07 |
Short-Term Debt Issued | - | 3.62 | 44.21 | 12.52 | - |
Long-Term Debt Issued | - | 2.55 | 116.3 | - | - |
Total Debt Issued | - | 6.17 | 160.51 | 12.52 | - |
Short-Term Debt Repaid | -3.52 | - | - | - | -109.03 |
Long-Term Debt Repaid | -53.61 | -51.59 | -155.36 | -55.54 | -10.46 |
Total Debt Repaid | -57.13 | -51.59 | -155.36 | -55.54 | -119.5 |
Net Debt Issued (Repaid) | -57.13 | -45.42 | 5.15 | -43.02 | -119.5 |
Common Dividends Paid | - | - | - | - | -121.79 |
Other Financing Activities | -0.62 | 5.04 | 0.26 | -16.82 | - |
Financing Cash Flow | -57.74 | -40.38 | 5.41 | -59.84 | -241.28 |
Foreign Exchange Rate Adjustments | -2.47 | 1.75 | -0.74 | 2.08 | -5.02 |
Net Cash Flow | 25.61 | 56.36 | -267.87 | -73.2 | -264.08 |
Free Cash Flow | 196.17 | 22.75 | -26.03 | 36.98 | -16.46 |
Free Cash Flow Growth | 762.17% | - | - | - | - |
Free Cash Flow Margin | 10.09% | 1.29% | -2.01% | 2.51% | -5.64% |
Free Cash Flow Per Share | 5.32 | 0.62 | -0.71 | 1.01 | -0.45 |
Cash Interest Paid | - | 6.16 | 6.34 | 5.24 | 1.66 |
Cash Income Tax Paid | - | 3.39 | 7.48 | 11.02 | 79.49 |
Levered Free Cash Flow | 199.32 | 27.06 | -18.41 | 17.75 | -5.09 |
Unlevered Free Cash Flow | 202.5 | 30.89 | -14.53 | 21 | -4.11 |
Change in Working Capital | 153.23 | -0.26 | -40.34 | -1.13 | 60.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.